Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 7
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Ischemic stroke patients are biologically older than their chronological age

  • Soriano Tárraga, Carolina|||0000-0002-5635-273X
  • Giralt Steinhauer, Eva|||0000-0002-7463-0983
  • Mola-Caminal, Marina
  • Vivanco-Hidalgo, Rosa Maria|||0000-0001-7547-0291
  • Ois, Angel|||0000-0002-1375-5950
  • Rodriguez Campello, Ana Maria|||0000-0001-8621-1420
  • Cuadrado Godia, Elisa|||0000-0002-9147-875X
  • Sayols-Baixeras, Sergi
  • Elosua, Roberto|||0000-0001-8235-0095
  • Roquer González, Jaume|||0000-0001-5992-2606
  • Jimenez-Conde, Jordi|||0000-0002-2623-6199
Ischemic stroke is associated with aging. It is possible to predict chronological age by measuring age-related changes in DNA methylation from multiple CpG sites across the genome, known as biological age. The difference between biological age and actual chronological age would indicate an individual's level of aging. Our aim was to determine the biological age of ischemic stroke patients and compare their aging with controls of the same chronological age. A total of 123 individuals, 41 controls and 82 patients with ischemic stroke were paired by chronological age, ranging from 39 to 82 years. Illumina HumanMethylation450 BeadChip array was used to measure DNA methylation in CpG sites in both groups, and biological age was estimated using methylation values of specific CpGs. Ischemic stroke patients were biologically an average 2.5 years older than healthy controls (p-value=0.010). Stratified by age tertiles, younger stroke patients (≤57 years old) were biologically older than controls (OR=1.19; 95%CI 1.00-1.41, p-value=0.046). The older groups showed no biological age differences between cases and controls, but were close to reaching the significance level. Ischemic stroke patients are biologically older than controls. Biological age should be considered as a potential new biomarker of stroke risk.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

GRECOS project (Genotyping Recurrence Risk of Stroke). The use of genetics to predict the vascular recurrence after stroke

  • Fernández Cadenas, Israel|||0000-0003-4821-2363
  • Mendioroz, Maite|||0000-0002-4179-5781
  • Giralt, Dolors
  • Nafría, Cristina
  • Garcia, Elena
  • Carrera, Caty|||0000-0002-0804-0969
  • Gallego Fabrega, Cristina|||0000-0003-3229-5512
  • Domingues-Montanari, Sophie
  • Delgado Martínez, María Pilar|||0000-0002-1628-4488
  • Ribo, Marc|||0000-0001-9242-043X
  • Castellanos, María del Mar|||0000-0003-3116-1352
  • Martínez, Sergi
  • Freijo, Mari Mar
  • Jimenez-Conde, Jordi|||0000-0002-2623-6199
  • Rubiera, Marta
  • Álvarez Sabín, José|||0000-0002-8054-9209
  • Molina, Carlos A.|||0000-0001-6058-6259
  • Font, Maria Angels
  • Grau Olivares, Marta
  • Palomeras, Ernest|||0000-0002-0724-8653
  • Pérez de la Ossa, Natalia|||0000-0002-6063-211X
  • Martinez Zabaleta, Maite
  • Masjuan, Jaime|||0000-0003-1329-0943
  • Moniche, Francisco|||0000-0001-8613-2909
  • Cánovas Verge, David|||0000-0002-3483-8106
  • Piñana, Carlos|||0000-0001-7316-6202
  • Purroy, Francisco|||0000-0002-1808-5968
  • Cocho, Dolores
  • Navas, Inmaculada
  • Tejero, Carlos
  • Aymerich, Nuria
  • Cullell, Natalia|||0000-0001-5118-1014
  • Muiño, Elena|||0000-0001-5839-7328
  • Serena, Joaquín|||0000-0002-4478-7744
  • Rubio, Francisco
  • Dávalos, Antoni|||0000-0003-2949-5679
  • Roquer González, Jaume|||0000-0001-5992-2606
  • Arenillas, Juan F.|||0000-0001-7464-6101
  • Martí-Fàbregas, Joan|||0000-0001-9229-8649
  • Keene, Keith
  • Chen, Wei-Min
  • Worrall, Bradford
  • Sale, Michele
  • Arboix, Adrià|||0000-0002-8512-7881
  • Krupinski, Jerzy|||0000-0002-5136-8898
  • Montaner, Joan|||0000-0003-4845-2279
Background and Purpose-Vascular recurrence occurs in 11% of patients during the first year after ischemic stroke (IS) or transient ischemic attack (TIA). Clinical scores do not predict the whole vascular recurrence risk, therefore we aimed to find genetic variants associated with recurrence that might improve the clinical predictive mode is in IS. Methods-We analyzed 256 polymorphisms from 115 candidate genes in three patient cohorts comprising 4,482 IS or TIA patients. The discovery cohort was prospectively recruited and included 1,494 patients, 6.2% of them developed a new IS during the first year of follow-up. Replication analysis was performed in 2,988 patients using SNPlex or HumanOmni1-Quad technology. We generated a predictive model using Cox regression (GRECOS score), and generated risk groups using a classification tree method. Results-The analyses revealed that rs1800801 in the MGP gene (HR: 1.33, p= 9×10-03), a gene related to artery calcification, was associated with new IS during the first year of follow-up. This polymorphism was replicated in a Spanish cohort (n=1.305), however it was not significantly associated in a North American cohort (n=1.683). The GRECOS score predicted new IS (p=3.2×10-09) and could classify patients, from low risk of stroke recurrence (1.9%) to high risk (12.6%). Moreover, the addition of genetic risk factors to the GRECOS score improves the prediction compared to previous SPI-II score (p=0.03). Conclusions-The use of genetics could be useful to estimate vascular recurrence risk after IS. Genetic variability in the MGP gene was associated with vascular recurrence in the Spanish population.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Estudio descriptivo de los stroke mimics después de un estudio neurovascular completo, Description of stroke mimics after complete neurovascular assessment

  • Avellaneda-Gómez, Carla|||0000-0003-4851-1224
  • Rodriguez Campello, Ana Maria|||0000-0001-8621-1420
  • Giralt Steinhauer, Eva|||0000-0002-7463-0983
  • Gomez Gonzalez, Alejandra|||0000-0001-7266-5253
  • Serra Martínez, Maria
  • de Ceballos Cerrajería, Pablo
  • Zabalza, Ana|||0000-0003-3860-5251
  • Cuadrado Godia, Elisa|||0000-0002-9147-875X
  • Ois, Angel|||0000-0002-1375-5950
  • Jimenez-Conde, Jordi|||0000-0002-2623-6199
  • Roquer González, Jaume|||0000-0001-5992-2606
Introducción: Un porcentaje de casos diagnosticados inicialmente como infartos isquémicos son de causa no cerebrovascular o stroke mimics (SM). Los datos publicados al respecto son heterogéneos y, generalmente, con cohortes pequeñas. Objetivo: Nuestro objetivo es establecer qué enfermedades cursan como SM, definir sus características epidemiológicas y clínicas e identificar el porcentaje de casos tratados con fibrinólisis. Métodos: Registro prospectivo de los eventos considerados cerebrovasculares desde junio del 2005 a abril del 2015, analizando datos demográficos, factores de riesgo cardiovascular, activación de Código Ictus e ingreso, severidad (NIHSS), destino al alta, morbilidad (mRS) y tratamiento recibido. Se han comparado los ictus isquémicos con los SM. Se excluyeron las hemorragias intracraneales, subaracnoideas y las causas de SM detectables en la TC inicial. Resultados: Sobre 4.570 casos, 404 (8,8%) son SM. Los pacientes con SM son más jóvenes (70,3 vs. 74 años, p < 0,0001), tienen menos factores de riesgo cardiovascular y fibrilación auricular (13 vs. 34%, p < 0,0001), una menor puntuación en NIHSS (2 vs. 4, p < 0,0001) y menos afasia (9,4 vs. 19,6%, p < 0,02) y disfagia (1,2 vs. 17%, p < 0,0001). En los SM se activan menos códigos ictus (28 vs. 40%, p < 0,0001) y requieren menos días de ingreso (4,9 vs. 7,8; p < 0,0001) y menos ingresos en la unidad de ictus (47 vs. 60%, p < 0,0001). Los SM son dados de alta a domicilio con mayor frecuencia (95 vs. 62%, p < 0,0001) y con menor discapacidad (mRS 0-2; 76 vs. 54%, p < 0,0001). Un 4,7% de los SM recibieron fibrinólisis. La primera causa de SM fueron las crisis epilépticas (26%). Conclusiones: Los SM supusieron el 8,8% de los ingresos con diagnóstico inicial de ictus isquémico. Los SM tienen características demográficas, clínicas y pronósticas diferentes, siendo la epilepsia la etiología más frecuente. Pese a recibir atención urgente especializada, 19 pacientes (4,7%) fueron trataron con fibrinólisis., Introduction: A considerable percentage of events initially diagnosed as ischaemic stroke have non-cerebrovascular causes; these are called stroke mimics (SM). Currently available evidence about these events is heterogeneous and comes from studies with small samples. Objective: The purpose of our study is to identify conditions that may present as SM, define their epidemiological and clinical characteristics, and determine the percentage of cases of SM treated with intravenous fibrinolysis. Methods: Prospective study including all patients admitted to a tertiary university hospital between June 2005 and April 2015 with a diagnosis of acute stroke. We analysed demographic data, cardiovascular risk factors, time from code stroke activation to admission, stroke severity (NIHSS), final destination after discharge, degree of disability (mRS), and treatment. We compared SM and ischaemic strokes. We ruled out patients with intracranial haemorrhage, subarachnoid haemorrhage, or other causes of SM that may be detected on the baseline CT scan. Results: Four hundred four of the 4,570 included patients (8.8%) were found to have SM. Patients with SM were younger (70.3 vs. 74, P <.0001), less likely to exhibit cardiovascular risk factors and atrial fibrillation (13 vs. 34%, P <.0001), scored lower on the NIHSS at baseline (2 vs. 4, P <.0001), and included fewer cases of aphasia (9.4 vs. 19.6%, P <.02) and dysphagia (1.2 vs. 17%, P <.0001) than patients with stroke. SM caused fewer code stroke activations (28 vs. 40%, P <.0001). Patients with SM required shorter hospital stays (4.9 vs. 7.8 days, P <.0001), were less frequently admitted to the stroke unit (47 vs. 60%, P <.0001) and more frequently discharged home (95 vs. 62%, P <.0001), and had better outcomes (mRS scores 0-2; 76 vs. 54%, P <.0001). Intravenous fibrinolysis was administered to 4.7% of these patients. Epileptic seizures were the most frequent cause of SM (26%). Conclusions: In our sample, 8.8% of all diagnoses of ischaemic stroke were SM. These events have different demographic, clinical, and prognostic characteristics; epilepsy is the most common aetiology. Despite receiving specialised emergency care, 19 patients with SM (4.7%) were treated with intravenous fibrinolysis.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Long-Term Stroke Recurrence after Transient Ischemic Attack, Implications of Etiology

  • Ois, Angel|||0000-0002-1375-5950
  • Cuadrado Godia, Elisa|||0000-0002-9147-875X
  • Giralt Steinhauer, Eva|||0000-0002-7463-0983
  • Jimenez-Conde, Jordi|||0000-0002-2623-6199
  • Soriano-Tarraga, Carolina
  • Rodriguez Campello, Ana Maria|||0000-0001-8621-1420
  • Avellaneda-Gómez, Carla|||0000-0003-4851-1224
  • Cascales, Diego
  • Fernandez-Perez, Isabel|||0000-0002-9949-1393
  • Roquer González, Jaume|||0000-0001-5992-2606
To analyze long-term stroke recurrence (SR) characteristics after transient ischemic attack (TIA) according to initial etiological classification. A prospective cohort of 706 TIA patients was followed up in a single tertiary stroke center. Endpoint was SR. Etiologic subgroup was determined according to the evidence-based causative classification system. Location of TIA and SR was recorded as right, left, or posterior territory. Disability stroke recurrence (DSR) was defined as modified Rankin Scale (mRS) score.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Detailed phenotyping of posterior vs. anterior circulation ischemic stroke, a multi-center MRI study

  • Frid, Petrea|||0000-0003-1452-2064
  • Drake, Mattias
  • Giese, Anne-Katrin
  • Wasselius, Johan|||0000-0003-1896-381X
  • Schirmer, Markus D.
  • Donahue, Kathleen L.
  • Cloonan, Lisa
  • Irie, Robert E.
  • Bouts, Mark|||0000-0003-2297-7499
  • McIntosh, Elissa C.
  • Mocking, Steven J. T.
  • Dalca, Adrian Vasile|||0000-0002-8422-0136
  • Sridharan, Ramesh
  • Xu, Huichun|||0000-0001-8118-9607
  • Giralt Steinhauer, Eva|||0000-0002-7463-0983
  • Holmegaard, Lukas
  • Jood, Katarina|||0000-0001-8746-1771
  • Roquer González, Jaume|||0000-0001-5992-2606
  • Cole, John W.|||0000-0001-9263-8930
  • McArdle, Patrick F.
  • Broderick, Joseph P.|||0000-0002-7323-7709
  • Jimenez-Conde, Jordi|||0000-0002-2623-6199
  • Jern, Christina
  • Kissela, Brett|||0000-0002-9773-4013
  • Kleindorfer, Dawn O.
  • Lemmens, Robin C.
  • Meschia, James Frederick
  • Rundek, Tatjana R.
  • Sacco, Ralph L.
  • Schmidt, Reinhold
  • Sharma, Pankaj K.
  • Slowik, Agnieszka Julia
  • Thijs, Vincent|||0000-0002-6614-8417
  • Woo, Daniel
  • Worrall, Bradford B.|||0000-0001-9386-4091
  • Kittner, Steven J.
  • Mitchell, Braxton|||0000-0003-4920-4744
  • Petersson, Jesper
  • M., Jonathan
  • Golland, Polina
  • Wu, Ona
  • Rost, Natalia Sana
  • Lindgren, Arne G.|||0000-0003-1942-7330
Posterior circulation ischemic stroke (PCiS) constitutes 20-30% of ischemic stroke cases. Detailed information about differences between PCiS and anterior circulation ischemic stroke (ACiS) remains scarce. Such information might guide clinical decision making and prevention strategies. We studied risk factors and ischemic stroke subtypes in PCiS vs. ACiS and lesion location on magnetic resonance imaging (MRI) in PCiS. Out of 3,301 MRIs from 12 sites in the National Institute of Neurological Disorders and Stroke (NINDS) Stroke Genetics Network (SiGN), we included 2,381 cases with acute DWI lesions. The definition of ACiS or PCiS was based on lesion location. We compared the groups using Chi-squared and logistic regression. PCiS occurred in 718 (30%) patients and ACiS in 1663 (70%). Diabetes and male sex were more common in PCiS vs. ACiS (diabetes 27% vs. 23%, p < 0.05 ; male sex 68% vs. 58%, p < 0.001). Both were independently associated with PCiS (diabetes, OR = 1.29; 95% CI 1.04-1.61; male sex, OR = 1.46; 95% CI 1.21-1.78). ACiS more commonly had large artery atherosclerosis (25% vs. 20%, p < 0.01) and cardioembolic mechanisms (17% vs. 11%, p < 0.001) compared to PCiS. Small artery occlusion was more common in PCiS vs. ACiS (20% vs. 14%, p < 0.001). Small artery occlusion accounted for 47% of solitary brainstem infarctions. Ischemic stroke subtypes differ between the two phenotypes. Diabetes and male sex have a stronger association with PCiS than ACiS. Definitive MRI-based PCiS diagnosis aids etiological investigation and contributes additional insights into specific risk factors and mechanisms of injury in PCiS. The online version of this article (10.1007/s00415-019-09613-5) contains supplementary material, which is available to authorized users.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Global DNA Methylation of Ischemic Stroke Subtypes

  • Soriano Tárraga, Carolina|||0000-0002-5635-273X
  • Jimenez-Conde, Jordi|||0000-0002-2623-6199
  • Giralt Steinhauer, Eva|||0000-0002-7463-0983
  • Mola, Marina
  • Ois, Angel|||0000-0002-1375-5950
  • Rodriguez Campello, Ana Maria|||0000-0001-8621-1420
  • Cuadrado Godia, Elisa|||0000-0002-9147-875X
  • Fernández Cadenas, Israel|||0000-0003-4821-2363
  • Carrera, Caty|||0000-0002-0804-0969
  • Montaner, Joan|||0000-0003-4845-2279
  • Elosua, Roberto|||0000-0001-8235-0095
  • Roquer González, Jaume|||0000-0001-5992-2606
Ischemic stroke (IS), a heterogeneous multifactorial disorder, is among the leading causes of mortality and long-term disability in the western world. Epidemiological data provides evidence for a genetic component to the disease, but its epigenetic involvement is still largely unknown. Epigenetic mechanisms, such as DNA methylation, change over time and may be associated with aging processes and with modulation of the risk of various pathologies, such as cardiovascular disease and stroke. We analyzed 2 independent cohorts of IS patients. Global DNA methylation was measured by luminometric methylation assay (LUMA) of DNA blood samples. Univariate and multivariate regression analyses were used to assess the methylation differences between the 3 most common IS subtypes, large-artery atherosclerosis (LAA), small-artery disease (SAD), and cardio-aortic embolism (CE). A total of 485 IS patients from 2 independent hospital cohorts (n = 281 and n = 204) were included, distributed across 3 IS subtypes: LAA (78/281, 59/204), SAD (97/281, 53/204), and CE (106/281, 89/204). In univariate analyses, no statistical differences in LUMA levels were observed between the 3 etiologies in either cohort. Multivariate analysis, adjusted by age, sex, hyperlipidemia, and smoking habit, confirmed the lack of differences in methylation levels between the analyzed IS subtypes in both cohorts. Despite differences in pathogenesis, our results showed no global methylation differences between LAA, SAD, and CE subtypes of IS. Further work is required to establish whether the epigenetic mechanism of methylation might play a role in this complex disease.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

The Role of HbA1c Determination in Detecting Unknown Glucose Disturbances in Ischemic Stroke

  • Roquer González, Jaume|||0000-0001-5992-2606
  • Rodriguez Campello, Ana Maria|||0000-0001-8621-1420
  • Cuadrado Godia, Elisa|||0000-0002-9147-875X
  • Giralt Steinhauer, Eva|||0000-0002-7463-0983
  • Jimenez-Conde, Jordi|||0000-0002-2623-6199
  • Soriano, Carol
  • Ois, Angel|||0000-0002-1375-5950
To evaluate the usefulness of hemoglobin A1c (HbA1c) determinations during the acute ischemic stroke (IS) to identify undiagnosed glucose disturbances in a prospective series of patients with first-ever IS. Retrospective analysis of a prospective series of first-ever IS patients. Patients with previous diagnosis of diabetes mellitus (DM) were excluded from the study. Patients were classified as non-DM (HbA1c<5.7% and no previous evidence of 2 or more fasting blood glucose.